368 related articles for article (PubMed ID: 10612511)
1. A study of the ability of tissue plasminogen activator to diffuse into the subretinal space after intravitreal injection in rabbits.
Kamei M; Misono K; Lewis H
Am J Ophthalmol; 1999 Dec; 128(6):739-46. PubMed ID: 10612511
[TBL] [Abstract][Full Text] [Related]
2. Effect of intravitreal tissue plasminogen activator on experimental subretinal hemorrhage.
Coll GE; Sparrow JR; Marinovic A; Chang S
Retina; 1995; 15(4):319-26. PubMed ID: 8545578
[TBL] [Abstract][Full Text] [Related]
3. Retinal Penetration of Intravitreally Injected Tissue Plasminogen Activator: A Rat Model Study.
Tal K; Dotan A; Nisgav Y; Dachbash M; Gal-Or O; Ehrlich R; Gaton DD; Weinberger D; Livnat T
Ophthalmic Res; 2018; 59(4):235-240. PubMed ID: 28728144
[TBL] [Abstract][Full Text] [Related]
4. A study of retinal penetration of intravitreal tenecteplase in pigs.
Kwan AS; Vijayasekaran S; McAllister IL; Yu PK; Yu DY
Invest Ophthalmol Vis Sci; 2006 Jun; 47(6):2662-7. PubMed ID: 16723484
[TBL] [Abstract][Full Text] [Related]
5. The use of intravitreal tissue plasminogen activator in the treatment of experimental subretinal hemorrhage in the pig model.
Boone DE; Boldt HC; Ross RD; Folk JC; Kimura AE
Retina; 1996; 16(6):518-24. PubMed ID: 9002136
[TBL] [Abstract][Full Text] [Related]
6. Tissue plasminogen activator treatment of experimental subretinal hemorrhage.
Lewis H; Resnick SC; Flannery JG; Straatsma BR
Am J Ophthalmol; 1991 Feb; 111(2):197-204. PubMed ID: 1899537
[TBL] [Abstract][Full Text] [Related]
7. Tissue plasminogen activator treatment of experimental subretinal hemorrhage.
Johnson MW; Olsen KR; Hernandez E
Retina; 1991; 11(2):250-8. PubMed ID: 1925092
[TBL] [Abstract][Full Text] [Related]
8. Intravitreal injection of tissue plasminogen activator and gas bubble for treatment of subretinal hemorrhage in ARMD.
Hay SR; Madonna RJ
Optometry; 2000 Nov; 71(11):715-21. PubMed ID: 11101129
[TBL] [Abstract][Full Text] [Related]
9. Management of acute submacular hemorrhage using recombinant tissue plasminogen activator and gas.
Hesse L; Schmidt J; Kroll P
Graefes Arch Clin Exp Ophthalmol; 1999 Apr; 237(4):273-7. PubMed ID: 10208258
[TBL] [Abstract][Full Text] [Related]
10. Treatment of experimental vitreous hemorrhage with tissue plasminogen activator.
Min WK; Kim YB; Lee KM
Korean J Ophthalmol; 1990 Jun; 4(1):12-5. PubMed ID: 2120486
[TBL] [Abstract][Full Text] [Related]
11. Tissue plasminogen activator thrombolysis during surgical evacuation of experimental subretinal hemorrhage.
Johnson MW; Olsen KR; Hernandez E
Ophthalmology; 1992 Apr; 99(4):515-21. PubMed ID: 1584568
[TBL] [Abstract][Full Text] [Related]
12. Injection site and pharmacokinetics after intravitreal injection of immunoglobulin G.
Miura Y; Uematsu M; Teshima M; Suzuma K; Kumagami T; Sasaki H; Kitaoka T
J Ocul Pharmacol Ther; 2011 Feb; 27(1):35-41. PubMed ID: 21182428
[TBL] [Abstract][Full Text] [Related]
13. Posterior vitreous detachment with microplasmin alters the retinal penetration of intravitreal bevacizumab (Avastin) in rabbit eyes.
Goldenberg DT; Giblin FJ; Cheng M; Chintala SK; Trese MT; Drenser KA; Ruby AJ
Retina; 2011 Feb; 31(2):393-400. PubMed ID: 21099453
[TBL] [Abstract][Full Text] [Related]
14. Retinal toxicity of recombinant tissue plasminogen activator in the rabbit.
Johnson MW; Olsen KR; Hernandez E; Irvine WD; Johnson RN
Arch Ophthalmol; 1990 Feb; 108(2):259-63. PubMed ID: 2105712
[TBL] [Abstract][Full Text] [Related]
15. [Intravitreal injection. Drugs to treat subretinal hemorrhage].
Hesse L
Ophthalmologe; 2012 Jul; 109(7):644-7. PubMed ID: 22752625
[TBL] [Abstract][Full Text] [Related]
16. Intravitreal injection of tissue plasminogen activator and gas in subretinal hemorrhage caused by age-related macular degeneration.
Krepler K; Kruger A; Tittl M; Stur M; Wedrich A
Retina; 2000; 20(3):251-6. PubMed ID: 10872929
[TBL] [Abstract][Full Text] [Related]
17. Retinal toxicity of commercial intravitreal tissue plasminogen activator solution in cat eyes.
Hrach CJ; Johnson MW; Hassan AS; Lei B; Sieving PA; Elner VM
Arch Ophthalmol; 2000 May; 118(5):659-63. PubMed ID: 10815158
[TBL] [Abstract][Full Text] [Related]
18. Fluorescein labeling of tissue plasminogen activator for subretinal thrombolysis.
Schneiderman TE; Johnson MW
Am J Ophthalmol; 1995 Dec; 120(6):797-8. PubMed ID: 8540555
[TBL] [Abstract][Full Text] [Related]
19. Quantitative effect of intravitreally injected tissue plasminogen activator and gas on subretinal hemorrhage.
Hesse L; Schroeder B; Heller G; Kroll P
Retina; 2000; 20(5):500-5. PubMed ID: 11039425
[TBL] [Abstract][Full Text] [Related]
20. Intravitreal and subretinal injection of tissue plasminogen activator (tPA) in the treatment of experimentally created retinal vein occlusion in rabbits.
Ameri H; Kim JG; Ratanapakorn T; Chader GJ; Humayun MS
Retina; 2008 Feb; 28(2):350-5. PubMed ID: 18301042
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
